耳石复位联合药物治疗对继发性良性阵发性位置性眩晕患者的临床效果分析

2020-12-23 06:53:05徐利李莹莹丁剑胡杨林
中国实用医药 2020年32期

徐利 李莹莹 丁剑 胡杨林

【摘要】 目的 探究在继发性良性阵发性位置性眩晕(BPPV)患者中采取耳石复位联合药物治疗的应用价值。方法 120例BPPV患者, 按照治疗方式不同分为研究组与对照组, 各60例。研究组予以耳石复位联合药物治疗, 对照组予以单纯耳石复位治疗。对比两组临床疗效、生活质量、不良反应发生率。结果 研究组临床总有效率为90.0%(54/60), 高于对照组的63.3%(38/60), 差异有统计学意义(P<0.05)。研究组躯体、情绪、功能评分和头晕残障(DHI)总分分别为(10.93±4.46)、(13.50±5.68)、(12.40±4.20)、(36.83±13.17)分, 均低于对照组的(15.43±4.59)、(19.23±4.36)、(18.07±4.07)、(53.02±12.42)分, 差异有统计学意义(P<0.05)。研究组不良反应发生率为3.3%, 低于对照组的15.0%, 差異有统计学意义(P<0.05)。结论 对继发性BPPV患者采用耳石复位联合药物治疗能明显提升患者临床疗效, 并且对患者生活质量有明显改善, 临床应用效果显著, 值得在临床上推广。

【关键词】 继发性良性阵发性位置性眩晕;耳石复位;药物治疗

DOI:10.14163/j.cnki.11-5547/r.2020.32.005

【Abstract】 Objective   To investigate the practical value of canalith repositioning maneuvers combined with drug therapy in patients with secondary benign paroxysmal positional vertigo (BPPV). Methods   A total of 120 BPPV patients were divided into research group and control group according to different treatment methods, with 60 cases in each group. The research group received canalith repositioning maneuvers combined with drug therapy, and the control group received canalith repositioning maneuvers only. The clinical efficacy, quality of life and incidence of adverse reactions were compared between the two groups. Results   The total clinical effective rate of the research group was 90.0%(54/60), which was higher than 63.3%(38/60) of the control group, and the difference was statistically significant (P<0.05). The physical, emotional, functional score, and dizziness handicap inventory (DHI) total scores of the research group were (10.93±4.46), (13.50±5.68), (12.40±4.20), (36.83±13.17) points, which were lower than (15.43±4.59), (19.23±4.36), (18.07±4.07), (53.02±12.42) points of the control group, and the difference was statistically significant (P<0.05). The incidence of adverse reactions of the research group was 3.3%, which was lower than 15.0% of the control group, and the difference was statistically significant (P<0.05). Conclusion   Canalith repositioning maneuvers combined with drug therapy can obviously improve the clinical efficacy of patients with secondary benign paroxysmal positional vertigo, and improve the quality of life of patients. It is worthy of clinical promotion.

【Key words】 Secondary benign paroxysmal positional vertigo; Canalith repositioning maneuvers; Drug therapy

良性阵发性位置性眩晕(benign pamxysmal positional vertigo, BPPV)属于一种外周性前庭疾病, 究其病理机制是由于体位变化而引起一种短暂性眩晕, 一旦头部运动到特定位置后即可引起眩晕症状, 且还会引发一系列自主神经症状[1, 2]。从该病病因上分析, 可分为特发性、继发性两种, 若病因不明则为特发性[3, 4], 若由于头部外伤、前庭神经炎、突发性聋、偏头痛、梅尼埃病、中耳炎、手术以及应用耳毒性药物等因素引起的则为继发性[5, 6]。临床治疗中以耳石复位为主要的治疗手段, 能明显缓解其眩晕症状, 但部分患者在治疗后临床症状仍然无法得到改善, 因而需要予以相应的药物治疗, 其药物的选择尤为重要。本研究特选取本院120例继发性BPPV患者, 分别采取不同的治疗方案, 探究耳石复位联合药物治疗的应用价值。

1 资料与方法

1. 1 一般资料 选择本院2016年5月~2019年5月收治的120例继发性BPPV患者为研究对象, 按照治疗方式不同分为研究组与对照组, 各60例。研究组男38例, 女22例, 年龄23~61岁, 平均年龄(48.1±8.4)岁;对照组男31例, 女29例, 年龄22~65岁, 平均年龄(43.3±7.6)岁。……

登录APP查看全文